HCA Healthcare Inc (NYSE:HCA) Shares Bought by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. boosted its position in shares of HCA Healthcare Inc (NYSE:HCA) by 16.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 31,368 shares of the company’s stock after buying an additional 4,480 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in HCA Healthcare were worth $3,904,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Nkcfo LLC bought a new stake in shares of HCA Healthcare in the fourth quarter valued at about $264,000. Royal London Asset Management Ltd. raised its holdings in HCA Healthcare by 51.6% in the fourth quarter. Royal London Asset Management Ltd. now owns 199,026 shares of the company’s stock worth $24,383,000 after purchasing an additional 67,729 shares in the last quarter. GWM Advisors LLC bought a new position in HCA Healthcare in the fourth quarter worth about $478,000. Reilly Financial Advisors LLC raised its holdings in HCA Healthcare by 3.0% in the fourth quarter. Reilly Financial Advisors LLC now owns 17,169 shares of the company’s stock worth $2,137,000 after purchasing an additional 505 shares in the last quarter. Finally, Arizona State Retirement System raised its holdings in HCA Healthcare by 6.6% in the fourth quarter. Arizona State Retirement System now owns 71,299 shares of the company’s stock worth $8,873,000 after purchasing an additional 4,399 shares in the last quarter. 72.85% of the stock is owned by institutional investors.

In related news, SVP Victor L. Campbell sold 28,084 shares of the firm’s stock in a transaction dated Monday, February 11th. The stock was sold at an average price of $138.97, for a total transaction of $3,902,833.48. Following the completion of the transaction, the senior vice president now directly owns 231,493 shares in the company, valued at approximately $32,170,582.21. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Deborah M. Reiner sold 523 shares of the firm’s stock in a transaction dated Thursday, January 31st. The shares were sold at an average price of $138.89, for a total value of $72,639.47. Following the transaction, the senior vice president now owns 4,927 shares of the company’s stock, valued at $684,311.03. The disclosure for this sale can be found here. Insiders sold a total of 40,976 shares of company stock valued at $5,703,133 over the last ninety days. Corporate insiders own 2.80% of the company’s stock.

A number of equities analysts have commented on HCA shares. Argus boosted their target price on shares of HCA Healthcare from $150.00 to $155.00 and gave the stock a “buy” rating in a report on Tuesday, November 6th. Zacks Investment Research upgraded HCA Healthcare from a “hold” rating to a “buy” rating and set a $157.00 price target on the stock in a research note on Monday, November 19th. UBS Group initiated coverage on HCA Healthcare in a research note on Thursday, November 15th. They set a “buy” rating and a $162.00 price target on the stock. Jefferies Financial Group boosted their price target on HCA Healthcare from $155.00 to $158.00 and gave the stock a “buy” rating in a research note on Wednesday, October 31st. Finally, Deutsche Bank initiated coverage on HCA Healthcare in a research report on Thursday, January 3rd. They issued a “buy” rating and a $140.00 target price on the stock. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and eighteen have given a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $148.43.

NYSE HCA opened at $140.89 on Thursday. HCA Healthcare Inc has a one year low of $93.03 and a one year high of $147.42. The firm has a market capitalization of $48.36 billion, a P/E ratio of 14.42, a PEG ratio of 1.16 and a beta of 0.80.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, January 29th. The company reported $2.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.59 by $0.40. HCA Healthcare had a negative return on equity of 91.25% and a net margin of 8.11%. The business had revenue of $12.27 billion during the quarter, compared to the consensus estimate of $12.10 billion. During the same period last year, the company earned $2.12 EPS. The company’s revenue for the quarter was up 6.2% on a year-over-year basis. Equities analysts predict that HCA Healthcare Inc will post 10.02 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, March 29th. Shareholders of record on Friday, March 1st will be paid a $0.40 dividend. The ex-dividend date is Thursday, February 28th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.35. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.14%. HCA Healthcare’s dividend payout ratio (DPR) is 14.33%.

COPYRIGHT VIOLATION WARNING: This news story was first posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this news story can be accessed at https://www.baseballdailydigest.com/news/2019/02/14/hca-healthcare-inc-hca-position-increased-by-oppenheimer-co-inc.html.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

See Also: What does EPS mean?

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply